ArticleEuropean radiology experimental2026
Sensitivity of physeal-metaphyseal tractography correlations with height velocity for fractional anisotropy threshold selection.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveDiffusion tensor imaging (DTI) tractography of the physeal-metaphyseal complex (PMC) provides insights into skeletal maturation. Fractional anisotropy (FA) minimal and maximal thresholds of 0.15 and 1.0, respectively, are commonly used to reconstruct tracts; these values were developed for highly organized tissues and may exclude the less organized hypertrophic and transitional zones that drive growth. Whether lowering the FA thresholds better captures growth-sensitive features and correlates with annualized height velocity is unknown. MATERIAL AND
methodsForty-five healthy adolescents (20 boys; 12-17 years) underwent 3 T DTI of the distal femoral PMC. Deterministic tractography was performed using nine previously untested FA threshold combinations (FA_min: 0.05, 0.10, 0.15 paired with FA_max: 0.40, 0.50, 0.60) and a conventional threshold (0.15-1.0). Partial Pearson correlations between extracted metrics (tract FA, apparent diffusion coefficient [ADC], volume) and annualized height velocity were computed, controlling for Tanner stage.
resultsTract ADC showed strong positive correlations with height velocity across all thresholds (r = 0.55-0.63). Tract FA showed consistent negative correlations (r = -0.38 to -0.45). Tract volume correlations were threshold-dependent: positive at lower FA_min thresholds (r = 0.33-0.37, at FA_min = 0.05) but attenuated or reversed at higher FA_min thresholds (r = -0.26, at 0.15-1.0).
conclusionTract ADC and FA are robust metrics of growth plate activity, insensitive to FA threshold selection. Tract volume associations with height velocity are threshold-dependent, with lower FA_min thresholds capturing growth-sensitive PMC tissue and lower FA_max excluding inactive PMC tissues. These findings underscore the importance of standardized tractography parameters in growth plate DTI studies. KEY POINTS: Question How can we prevent conventional DTI FA thresholds from underestimating growth-sensitive tract volumes in the pediatric PMC? Findings Lower FA thresholds accurately capture tract volume correlations with height velocity, while tract ADC and FA correlate reliably across all thresholds. Relevance statement Optimizing FA thresholds in physeal-metaphyseal-complex DTI improves microstructural imaging correlations with height velocity, ensures reproducible data in pediatric skeletal growth studies, enhances noninvasive skeletal growth monitoring in adolescents, and potentially supplements traditional bone-age radiographs.
Indexed as
Identifiers
42909757What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.